Healthcare

Request for TOC Request for Sample
BUY NOW

Global Glucose Tolerance Test Market – Industry Trends and Forecast to 2028

Healthcare | Upcoming Report | Mar 2021 | Global | 350 Pages | No of Tables: 60 | No of Figures: 220

Report Description

Global Glucose Tolerance Test Market, By Product Type (Smart Sensors, Blood Glucose Testing Kit, Others), Disease Indication (Reactive Hypoglycemia, Diabetes, Hypoglycemia, Gestational Diabetes, Insulin Resistance), End User (Hospitals, Home, Diagnostic Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Get Exclusive Sample Copy of this Report Here

Market Analysis and Insights of Glucose Tolerance Test : Global Glucose Tolerance Test Market

Glucose tolerance test market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 75,567.54 million by 2028 and will grow at a CAGR of 10.05% in the above mentioned forecast period.

The capacity to absorb glucose from our body cells after the consumption of a few amount of sugar is measured with the help of glucose tolerance test. This test is largely used to diagnose diabetes. It has its main application in screening all pregnant women for gestational diabetes, as it can cause further complications during pregnancy.

The increasing research that are funding in the diabetes treatment and diagnosis is amongst the significant factors fueling the growth and demand of glucose tolerance test market. In addition, the growing awareness and screening for diabetes mellitus and growing prevalence and incidence of diabetes mellitus are also contributing to the growth in the global market over the forecast period of 2021 to 2028. Also the rapid technological innovations and increasing research funding in diabetes diagnosis and treatment are also lifting the growth of the market. Furthermore, the increasing capita disposable incomes as well as the presence of well-developed technology and high healthcare expenditure are also the significant factors flourishing the growth of the glucose tolerance test market.

The rapid increase in technological innovations as well as the increasing research funding in diabetes diagnosis and treatment and growing demand of home care of diabetes are offering significant growth opportunities for the market in the forecast period of 2021 to 2028.

However, the high-cost associated with diagnosis and treatment of diabetes as well as the strict stringent reimbursement and insurance policies in developing nations will limit the growth of the glucose tolerance test market, whereas the easy availability of cheaper alternative technologies has the potential to challenge the growth of the glucose tolerance test market.

This glucose tolerance test market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on glucose tolerance test market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Glucose Tolerance Test Market Scope and Market Size

Glucose tolerance test market is segmented on the basis of product type, disease indication and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of product type, the glucose tolerance test market is segmented into smart sensors, blood glucose testing kit and others. Blood glucose testing kit has further been segmented into lancet, meters and test strips.
  • Glucose tolerance test market can is segmented on the basis of disease indication into reactive hypoglycemia, diabetes, hypoglycemia, gestational diabetes and insulin resistance.
  • The end user segment of glucose tolerance test market is segmented into hospitals, home, diagnostic clinics and others.

Glucose Tolerance Test Market Country Level Analysis

Glucose tolerance test market is analyzed and market size insights and trends are provided by country, product type, disease indication and end user as referenced above.

The countries covered in the glucose tolerance test market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the glucose tolerance test market owing to the rising prevalence of diabetes mellitus, presence of well-developed technology and increasing healthcare expenditure within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rapidly changing healthcare sector as well as the rising government support for research and development in this particular region.

The country section of the glucose tolerance test market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Glucose tolerance test market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for glucose tolerance test market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the glucose tolerance test market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Glucose Tolerance Test Market Share Analysis

Glucose tolerance test market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to glucose tolerance test market.

The major players covered in the glucose tolerance test market report are Thermo Fisher Scientific Inc., Medtronic, NIPRO, Trividia Health, Inc., Dexcom, Inc., Healius Limited, Penlan Healthcare Ltd, Quest Diagnostics Incorporated, Johnson & Johnson Services, Inc., Abbott, Laboratory Corporation of America Holdings., ARUP Laboratories., Cleveland HeartLab, Inc., Merck KGaA, Bayer AG, Ascensia Diabetes Care Holdings AG, E-Zlab Health Services, F. Hoffman-La Roche Ltd, LifeScan IP Holdings, LLC and Sanofi among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Table of Content

Please fill in the below form for detailed Table of Content

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Table

Please fill in the below form for detailed List of Table

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Figure

Please fill in the below form for detailed List of Figure

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

View Infographics

Please fill in the below form for detailed Infographics

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country
CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19